جستجوی استاد راهنمای دانشگاهی

Keith Alexander Sharkeyمشاهده پروفایل

استاد

• Enteric nervous system
• Gut-brain axis
• Endocannabinoid system
• +۳ مورد دیگر

Dr. Keith Alexander Sharkey is a Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He is also a Full Member of both the Hotchkiss Brain Institute and The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases. Dr. Sharkey has been at the University of Calgary since his appointment as Assistant Professor in 1990, dedicating his career to understanding the neural control of the gastrointestinal tract. From 2005-2021, he held the Crohn's and Colitis Canada Chair in Inflammatory Bowel Disease Research, demonstrating his longstanding commitment to advancing knowledge in gastrointestinal sciences. Dr. Sharkey's educational journey began with a BSc (Hons) in Nutrition from the University of London in 1981, followed by a PhD in Physiology from the University of Liverpool in 1985. After completing postdoctoral training in Hungary, the UK, and Canada, he joined the University of Calgary faculty in 1990, where he has remained throughout his distinguished academic career. Dr. Sharkey's research program centers on understanding the physiology and pathophysiology of the neural control of the gastrointestinal tract and brain-gut interactions in health and disease. His laboratory investigates two main areas: the role of the endocannabinoid system in regulating GI motility and intestinal barrier function, and the physiology of the enteric nervous system in controlling motility and barrier function. His work employs state-of-the-art approaches including live cell imaging and molecular genetics. Recent publications show his expanding interest in connections between gut function and neurodegenerative conditions like ALS, with multiple 2024-2025 papers examining sexual dimorphism in disease processes and gut-brain axis mechanisms. Fellow, Royal Society of Canada (2024) Cumming School of Medicine's van de Sande Distinguished Achievement Award for Mentorship (2021) Distinguished Research Award, American Physiological Society (2021) Finkelstein Award for Excellence, Crohn's and Colitis Canada (2016) Fellow, Canadian Academy of Health Sciences (2015) Fellow, Canadian Association of Gastroenterology (2015) Killam Annual Professor Award, University of Calgary (2013) Dr. Sharkey has mentored numerous students throughout his career, as evidenced by his 2021 Mentorship Award. His research is supported by significant funding, including a CIHR Foundation grant exploring how enteric nerves and glia maintain intestinal homeostasis. He has also participated in university strategic initiatives focused on Brain and Mental Health (2015-2021) and Infections, Inflammations and Chronic Diseases (2015-2021), demonstrating his interdisciplinary approach. The Sharkey Lab provides a safe, inclusive, and diverse research environment that encourages open scientific exchange from diverse viewpoints. His laboratory is actively engaged in multiple collaborative projects, including investigations with UBC Okanagan on diet and probiotics targeting the gut-brain metabolic interactome, and with University of Calgary colleagues studying gut microbiota's role in ALS. Dr. Sharkey continues to advance our understanding of neural mechanisms controlling gastrointestinal function with upcoming courses scheduled for Fall 2024 and Winter 2025.

Vikramaditya G. Yadavمشاهده پروفایل

دانشیار

• Biocatalysis
• Bioremediation
• Bioprocess engineering
• +۱۵ مورد دیگر

Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.

Mengliang Zhangمشاهده پروفایل

دانشیار

• Forensic Chemistry
• Food and Agricultural Chemistry
• Metabolomics
• +۱۲ مورد دیگر

Mengliang Zhang is an Associate Professor in the Department of Chemistry and Biochemistry at Ohio University, College of Arts and Sciences. He leads an interdisciplinary research group focused on mass spectrometry and chemometrics, with applications in forensic, food, agricultural, environmental, and material sciences. His lab develops innovative analytical strategies for detecting toxicants, characterizing nanomaterials, and profiling metabolites in botanicals and food systems. Ph.D., Chemistry, Ohio University, 2015 Dr. Zhang’s research integrates instrumentation, chemometrics, and computational tools to address complex analytical challenges. His group works on forensic fiber and ignitable liquid analysis, plant metabolomics, nanomaterial surface chemistry, and environmental toxicant monitoring. His work is highly interdisciplinary, bridging chemistry, data science, and real-world applications in forensics and public health. His recent publications demonstrate a strong trend in advancing ambient ionization mass spectrometry (especially DART-MS), chemometric modeling, and metabolite profiling across diverse matrices—from fire debris to broccoli microgreens. His work increasingly emphasizes automation, quantitation, and database development for botanical phytochemicals. Scientific honors include the MTSU Distinguished Research Award (Early Career), and his students have received prestigious awards such as the Goldwater Scholarship and multiple URECA recognitions. He is actively supported by federal grants from NSF, USDA, DOE, DOJ (NIJ), and FEMA. Dr. Zhang mentors a vibrant research team of graduate and undergraduate students, guiding them in publishing high-impact research and presenting at national conferences like ASMS, Pittcon, and AAFS. He has organized sessions at SciX and served on editorial boards of Journal of Forensic Sciences and Journal of AOAC INTERNATIONAL . His lab recently relocated to Ohio University in August 2024, equipped with advanced instrumentation including UHPLC-QTOF-MS and DART-MS systems.

Aditi Dasمشاهده پروفایل

استاد

• Biochemistry and Chemical biology of Lipids
• Mechanism of Membrane proteins in Nanodiscs
• Enzymology of metalloproteins
• +۵ مورد دیگر

Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.

Scott Hopkinsمشاهده پروفایل

استاد

• Physical Chemistry
• Machine Learning
• Mass Spectrometry
• +۲ مورد دیگر

Scott Hopkins is a Professor in the Department of Chemistry at the University of Waterloo, specializing in Physical Chemistry. His research integrates machine learning with experimental techniques to study ion mobility, mass spectrometry, and spectroscopic analysis. He directs the Hopkins Laboratory, focusing on computational predictions of chemical behaviors and molecular interactions. His work addresses fundamental questions in gas-phase chemistry, cluster formation, and analytical method development. Research interests span physical chemistry, computational modeling, and analytical instrumentation, with a strong emphasis on developing predictive tools for complex chemical systems. Recent investigations explore ion-solvent dynamics, fragmentation mechanisms, and machine-learning applications for spectral interpretation.

Outi Salo-Ahenمشاهده پروفایل

مدرس ارشد

• Pharmaceutical Chemistry
• Molecular Modeling
• Drug Design
• +۵ مورد دیگر

Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.

Keith Edmistenمشاهده پروفایل

استاد

• Agronomy
• Crop Physiology
• Industrial Hemp Production
• +۳ مورد دیگر

Keith Edmisten is a Professor in the Department of Crop and Soil Sciences at NC State University, serving as Extension Cotton Specialist and Director of Undergraduate Programs. He holds a BS, MS from NC State University, and a PhD in Crop Physiology from Virginia Tech (1987). His career includes faculty roles at Mississippi State University and Auburn University before joining NCSU in 1992. His research focuses on cotton and industrial hemp agronomy, germplasm evaluation, and regulatory science in agriculture. Notable awards include Extension Cotton Specialist of the Year (1997) and Cotton Physiologist of the Year (2015). He teaches courses on biotechnology, seed science, and regulatory frameworks, and advises students in the Plant and Soil Science biotechnology concentration. Edmisten's program integrates applied research with extension efforts, emphasizing sustainable input management, variety trials, and on-farm experimentation. Collaborations span departments like Entomology, Plant Pathology, and Agricultural Economics. Publications highlight fertilizer management, weed science, and crop modeling in cotton and hemp systems.

Steff Lewisمشاهده پروفایل

استاد

• Medical Statistics
• Clinical Trials
• Epidemiology
• +۳ مورد دیگر

Steff Lewis is a Professor of Medical Statistics at the University of Edinburgh , affiliated with the Usher Institute within the College of Medicine and Veterinary Medicine . She leads the statistics group at the Edinburgh Clinical Trials Unit and holds roles in the Deanery of Molecular, Genetic and Population Health Sciences . Her expertise spans meta-analysis, randomized trial design, and clinical trial governance, with involvement in Cochrane Collaboration and UK Clinical Research Collaboration initiatives. Education: MSc and PhD in Medical Statistics. Research Interests: Focuses on methodological advancements in clinical trial reporting (e.g., CONSORT and SPIRIT guidelines), cardiovascular outcomes (e.g., SCOT-HEART trial), stroke prevention (ASPIRING trial), and ethical data management. She actively contributes to international standards for trial protocols, anonymization practices, and statistical validation. Recent Contributions: Over 200 peer-reviewed articles and 37 ongoing projects, including leadership in trials assessing antiplatelet therapies, Paget’s disease interventions, and pediatric asthma treatments. Collaborates globally on guidelines for randomized trials and data-sharing protocols. Grants & Teams: Principal or co-investigator on projects funded by NIHR, BHF, and ESRC, including trials on iron therapy in critical care (INTACT-2) and cannabinoid treatments for endometriosis pain (ENDO-CAN). Leads multidisciplinary teams integrating statistical rigor with clinical innovation. Labs/Teams: Embedded within the Edinburgh Clinical Trials Unit and the Centre for Population Health Sciences , fostering collaborative research across molecular, genetic, and public health domains.

• Environmental Toxicology
• Reproductive Health
• Metabolic Disorders
• +۳ مورد دیگر

Dr. Alison Holloway is a Professor at McMaster University's Faculty of Health Sciences, specializing in environmental toxicology and reproductive health. Her research focuses on the effects of environmental contaminants (e.g., oil sands pollutants, pesticides, endocrine disruptors) on maternal and child health, metabolic disorders, and developmental outcomes. She has conducted studies on naphthenic acids, synthetic food additives, and maternal exposure to pharmaceuticals like fluoxetine. Key research areas include: Environmental contaminants' impact on reproductive systems and placental function Metabolic disturbances caused by chemical exposures during critical developmental windows Neurobehavioral and gastrointestinal effects of prenatal drug exposure Assessment of urban air pollution on in vitro fertilization (IVF) success rates Her recent work highlights the role of the tryptophan-kynurenine pathway as a biomarker of environmental stress and the obesogenic effects of bisphenol analogs and food additives. Collaborations involve interdisciplinary teams addressing environmental health, with studies published in high-impact toxicology and public health journals. Dr. Holloway's research has informed policies on chemical safety and maternal health, emphasizing cross-species markers for organismal health and risk assessment of emerging contaminants like cannabis derivatives.

Mohsen Yoosefzadeh Najafabadiمشاهده پروفایل

استادیار

• Dry Bean Breeding
• Computational Biology
• Omics-Based Selection
• +۵ مورد دیگر

Dr. Mohsen Yoosefzadeh Najafabadi is an Assistant Professor in the Department of Plant Agriculture at the University of Guelph, Ontario Agricultural College. He holds a PhD in Plant Breeding from the University of Guelph (2022), following M.Sc. and B.Sc. degrees from the University of Tehran. His research focuses on dry bean breeding, computational biology, and integrating omics technologies to enhance crop resilience and productivity. Key areas include developing stress-tolerant dry bean varieties, leveraging remote sensing for trait prediction, and optimizing genomic selection methods. He leads the Dry Bean Breeding & Computational Biology Program and has contributed to over 30 peer-reviewed publications since 2017. Education : PhD, Plant Breeding, University of Guelph (2022) M.Sc., University of Tehran B.Sc., University of Tehran Research interests emphasize computational tools development (e.g., AllInOne preprocessing framework), omics-based selection strategies, and non-Mendelian heredity mechanisms. His lab combines machine learning with field phenotyping to address agricultural challenges such as disease resistance and climate adaptation. Collaborative projects include soybean cold stress analysis and cannabinoid profile prediction in cannabis. Publications span genomic approaches to crop improvement, remote sensing applications, and transcriptomic studies. He teaches courses in plant breeding methodologies and actively engages in technology transfer initiatives. Lab activities include developing high-yielding dry bean cultivars resistant to biotic/abiotic stresses and advancing data-driven pipelines for crop breeding. Future work aims to synergize AI with multi-omics data to enhance crop resilience in diverse environments.

Jashvant Unadkatمشاهده پروفایل

استاد

• Pharmacokinetics
• Pharmacodynamics
• Drug Transporters
• +۷ مورد دیگر

Jashvant Unadkat, Ph.D. is a Professor of Pharmaceutics at the University of Washington School of Pharmacy. He holds appointments in the Department of Pharmaceutics and is actively involved with the UWPKDAP (Program on Pharmacokinetics of Drugs of Abuse during Pregnancy). His research spans drug transport, metabolism, and pharmacokinetics with special emphasis on pregnancy and fetal pharmacology. Dr. Unadkat received his B.Pharm. from the University of London (1977), his Ph.D. from the University of Manchester (1982), and completed postdoctoral training at the University of California at San Francisco (1982-85). His educational background laid the foundation for his extensive career in pharmaceutical sciences. His research interests focus on mechanisms of drug transport and metabolism, particularly during pregnancy. Dr. Unadkat has made significant contributions to understanding placental drug transporters, blood-brain barrier function, and quantitative approaches to pharmacokinetics-pharmacodynamics. His work bridges computational modeling with experimental approaches to address complex questions in drug disposition. Analysis of his recent publications reveals a strong trend toward understanding drug interactions during pregnancy, cannabinoid pharmacology, and the application of physiologically based pharmacokinetic (PBPK) modeling to predict drug behavior in special populations. His research spans pharmacology, computational biology, obstetrics, and toxicology with particular emphasis on drug transporters and their regulation. Fellow of AAAS Fellow of AAPS Fellow of JSSX AAPS Research Achievement Award (2012) ISSX Research Achievement Award (2023) Founding co-chair (1999-2001) of AAPS focus group on Drug Transport and Uptake Dr. Unadkat has led significant research initiatives including the UW Research Affiliates Program on Transporters (UWRAPT) for 10 years, the NIDA-funded UWPKDAP program on drug disposition during pregnancy, and co-leads the NICHD-funded UW Transporter Elucidation Center. His work has generated over 250 peer-reviewed publications and has significantly influenced regulatory science and drug development practices. He is actively involved in research teams focusing on placental transport, hepatic drug metabolism, and quantitative pharmacology. His current work with the UW Transporter Elucidation Center aims to identify and characterize novel transporters in the placenta and developing intestine, with implications for drug safety during pregnancy and pediatric pharmacotherapy.

John Barrowمشاهده پروفایل

استاد

• Biochemistry
• Molecular Biology
• Virtual Reality Education
• +۳ مورد دیگر

Professor John Barrow is a Professor of Biochemistry & Molecular Biology at the University of Aberdeen, where he also serves as Dean for Employability and Entrepreneurship since 2020. He is affiliated with the School of Medicine, Medical Sciences and Nutrition, based at the Institute of Medical Sciences on the Foresterhill Campus with office address at Ashgrove Road West, AB25 2ZD. Barrow earned his academic qualifications entirely from the University of Aberdeen: a BSc(Hons) in Biochemistry (2002), PhD in Molecular Biology (2005), and PGCert in Higher Education (2011). He was awarded Senior Fellow status with the Higher Education Academy in 2015. His academic career at Aberdeen has progressed from Postdoctoral research scientist (2005-2009), through Teaching Fellow (2009-2013) and Senior Teaching Fellow (2013-2015), to Senior Lecturer (Scholarship) (2015-2021), before becoming Professor in 2021. Professor Barrow's research primarily focuses on innovative approaches to biochemistry education, with particular emphasis on virtual reality and immersive learning technologies. His work bridges traditional biochemical knowledge with cutting-edge educational methodologies, creating engaging learning experiences for students. He has pioneered the use of virtual reality for teaching complex biochemical concepts such as the citric acid cycle and molecular structures. Additionally, his research extends to graduate attributes development, employability skills, and entrepreneurship education, reflecting his dual role as both educator and Dean for Employability and Entrepreneurship. Analysis of his recent publications reveals a strong trend toward educational technology and innovative teaching methods, particularly virtual and augmented reality applications in biochemistry education. His work spans molecular biology education, skills development, and the integration of enterprise and entrepreneurship into the academic curriculum. While his earlier career included more traditional molecular biology research on topics like gene promoters and receptor pathways, his recent focus has shifted predominantly toward educational innovation. His professional recognition includes: Senior Fellow of the Higher Education Academy (2015) As Dean for Employability and Entrepreneurship, Professor Barrow oversees initiatives that connect academic learning with real-world applications, including the ABDN Grad Challenge and Hack 2040 ideathon events. His work focuses on developing students' enterprise skills and preparing them for diverse career paths. He has been instrumental in creating programs like the Employability Boost Award, designed to enhance students' career readiness through structured skill development. Professor Barrow is actively involved in curriculum development at the University of Aberdeen, particularly in transforming and embedding graduate attributes across programs. His leadership extends to external examiner roles for institutions in Pakistan and reviewing for major academic publishers and journals. His innovative approach to education has positioned him as a leader in educational technology within the medical and biochemical sciences.

Emma Lynchمشاهده پروفایل

مدرس

• Meat Science
• Ruminant Nutrition
• Animal Handling
• +۴ مورد دیگر

Dr. Emma Lynch is a Lecturer in Ruminant Production at the School of Environmental and Rural Science , University of New England. Her research focuses on evaluating novel feedstuffs and their impacts on ruminant production, meat quality, and sensory attributes. Education PhD in Ruminant Nutrition, Charles Sturt University Bachelor of Animal Science (Hons), Charles Sturt University Research Interests encompass meat science , ruminant nutrition , protein supplementation , and alternative feed sources . Her work investigates how feed composition affects animal performance, nutrient digestibility, and meat quality, with a notable emphasis on canola meal and hemp biomass in ruminant diets. Recent publications highlight trends in feedstuff evaluation , rumen physiology , and meat quality assessment . She employs comparative methodologies (in vivo, in sacco, in vitro) to study digestibility and uses sensory panels to evaluate consumer preferences. Scientific Memberships NSW Branch Secretary, Australian Association of Animal Sciences (AAAS) Australian Intercollegiate Meat Judging Association Contact : elynch20@une.edu.au

David A. Galloمشاهده پروفایل

استاد

• Cognitive Neuroscience
• Memory Accuracy and Distortion
• Aging and Alzheimer’s Disease
• +۳ مورد دیگر

David A. Gallo is a Professor at the University of Chicago, affiliated with the Department of Psychology. He joined the faculty in 2005 after completing a B.A. at Wesleyan University (1997), a Ph.D. at Washington University in St. Louis (2002), and an NIH-sponsored postdoctoral fellowship at Harvard University. His research focuses on neurocognitive processes of human memory, particularly memory accuracy, distortion, aging effects, and Alzheimer’s disease. He explores how memory is actively reconstructed and influenced by contextual and pharmacological factors. Key research interests include metacognitive and nonconscious processes, cognitive neuroscience, and evolutionary psychology. He investigates how stereotypes, psychoactive drugs, and contextual cues affect memory accuracy and monitoring. His lab, the Memory Research Lab, employs neuroimaging, behavioral experiments, and pharmacological interventions to study these phenomena. His recent articles highlight studies on transcranial direct current stimulation (tDCS), contextual reinstatement effects, and drug-induced memory modulation. He emphasizes the role of distinctiveness in reducing memory errors and examines the neural mechanisms underlying retrieval monitoring. His work spans developmental, clinical, and applied domains, with implications for aging populations and cognitive health. Gallo teaches courses such as Cognitive Neuroscience of Aging and Evolutionary Psychology, integrating empirical research with theoretical frameworks. His contributions bridge basic science and clinical applications, addressing challenges in memory disorders and cognitive enhancement strategies.

Fadia Kamalمشاهده پروفایل

دانشیار

• Osteoarthritis Research
• Chondrocyte Biology
• Cartilage Homeostasis
• +۵ مورد دیگر

Fadia Kamal, PharmD, PhD is an Associate Professor holding dual appointments in the Department of Orthopaedics and Rehabilitation and the Department of Cell and Biological Systems. She leads research at the Center for Cannabis and Natural Product Pharmaceuticals (CCNPP) with a strong publication record including 33 research outputs and an h-index of 18 based on Scopus data. Dr. Kamal's research focuses on cellular pathways that control chondrocyte homeostasis in healthy tissue and the pathological processes leading to cartilage damage in osteoarthritis. Her work investigates how chondrocytes transform into pathological cells that cause cartilage degradation, with particular interest in discovering new pathways and drugs to control chondrocyte behavior and potentially reverse osteoarthritis progression. Her laboratory also explores the therapeutic potential of non-euphorigenic cannabis compounds for bone fracture pain management and healing. Her recent publications demonstrate a strong trend toward interdisciplinary research combining orthopedics, molecular biology, immunology, and pharmacology. The work spans from fundamental cellular mechanisms in osteoarthritis to applied therapeutic development, with particular emphasis on cannabis-based treatments, immune responses in fracture healing, and novel imaging techniques. Her research shows increasing collaboration across multiple institutions and disciplines. Scientific Awards: Samuel Hinkle Junior Faculty Research Scholar Award (2022) - widely recognized with coverage by 5 news outlets, blogged by 1 source, posted by 38 X users, and shared on 1 Facebook page with 33 Mendeley readers Dr. Kamal serves as Principal Investigator on significant research projects, most notably the NIH-funded 'Therapeutic targeting of GPCR Gbetagamma-GRK2 in osteoarthritis' project (2019-2023) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Her mentorship is evident through numerous co-authored publications with junior researchers who appear to be her students and postdoctoral fellows. She maintains active collaborations across immunology, bone healing, and natural product pharmacology research areas. Her work contributes to UN Sustainable Development Goals related to health and well-being, with research spanning osteoarthritis, heart failure progression, chondrocyte biology, and G protein-coupled receptor research. The Kamal lab maintains strong connections with the Center for Cannabis and Natural Product Pharmaceuticals, indicating a specialized research focus on natural compounds for musculoskeletal conditions.